{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:03:00Z","timestamp":1791219780205,"version":"4.1.0"},"reference-count":37,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T00:00:00Z","timestamp":1638835200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>To evaluate the association of conversion from valganciclovir to letermovir on cytomegalovirus\u2010specific cellular immunity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Adult patients were included if they received a kidney or liver transplant between 8\/1\/2018\u201012\/31\/20, developed symptomatic, high\u2010level CMV viremia and were converted to letermovir 480\u00a0mg daily as monotherapy after treatment with ganciclovir\u2010derivatives for a minimum of 4\u00a0weeks and had subsequent CMV cell\u2010mediated immunity (CMI) testing via ICS assay by flow cytometry (Viracor Eurofins T Cell Immunity Panel).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Seven patients met inclusion criteria; 87.5% were male and recipients of a kidney transplant. All patients were CMV high risk (D+\/R\u2010). Mean time from transplant to CMV disease was 200\u00a0\u00b1\u00a091 days. Peak viral load (VL) during CMV treatment was 540,341\u00a0\u00b1\u00a0391,211 IU\/mL. Patients received a mean of 30\u00a0\u00b1\u00a024\u00a0weeks (range: 4\u201078\u00a0weeks) of therapy with ganciclovir\u2010derivatives at induction doses prior to letermovir introduction. The median absolute lymphocyte count (ALC) at letermovir initiation was 400\/\u03bcL (IQR 575) and the median VL was 51.6 (range: ND\u2010490) IU\/mL. Most patients (n\u00a0=\u00a05\/7, 71.4%) experienced an increase in VL 1 and\/or 2\u00a0weeks after conversion to letermovir. All patients had positive CMI per ICS assay after conversion. Patients received a mean of 10.3\u00a0\u00b1\u00a06.9\u00a0weeks of letermovir prior to having a positive result. Median ALC at positivity was 900\/\u03bcL. Immunosuppression was not further reduced from initiation of letermovir to demonstration of CMV CMI. No patient had progressive replication or breakthrough disease while maintained on letermovir and three patients (42.9%) underwent antiviral withdrawal without recurrence at the last follow\u2010up.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In this case series of abdominal transplant recipients with severe or persistent CMV infection, patients developed CMV\u2010specific CMI after conversion to letermovir monotherapy. These data suggest that using letermovir in place of valganciclovir for secondary prophylaxis may address the lack of efficacy previously seen with this approach, as well as the issues that plague antiviral withdrawal with systematic monitoring. Future prospective studies are needed to evaluate this effect in a more controlled research environment with serial CMI testing to elucidate the optimal duration of letermovir when used in this way<\/jats:p><\/jats:sec>","DOI":"10.1111\/tid.13766","type":"journal-article","created":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T09:13:59Z","timestamp":1637399639000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Letermovir conversion after valganciclovir treatment in cytomegalovirus high\u2010risk abdominal solid organ transplant recipients may promote development of cytomegalovirus\u2010specific cell mediated immunity"],"prefix":"10.1111","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6088-9727","authenticated-orcid":false,"given":"Margaret R","family":"Jorgenson","sequence":"first","affiliation":[{"name":"Department of Pharmacy University of Wisconsin Hospital and Clinics Madison Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Kleiboeker","sequence":"additional","affiliation":[{"name":"Department of Pharmacy University of Wisconsin Hospital and Clinics Madison Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7001-2168","authenticated-orcid":false,"given":"Neetika","family":"Garg","sequence":"additional","affiliation":[{"name":"Department of Medicine Division of Nephrology University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1667-7465","authenticated-orcid":false,"given":"Sandesh","family":"Parajuli","sequence":"additional","affiliation":[{"name":"Department of Medicine Division of Nephrology University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3326-8583","authenticated-orcid":false,"given":"Didier A","family":"Mandelbrot","sequence":"additional","affiliation":[{"name":"Department of Medicine Division of Nephrology University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1096-464X","authenticated-orcid":false,"given":"Jon S","family":"Odorico","sequence":"additional","affiliation":[{"name":"Department of Surgery Division of Transplantation University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6656-981X","authenticated-orcid":false,"given":"Christopher M","family":"Saddler","sequence":"additional","affiliation":[{"name":"Department of Medicine Division of Infectious Diseases University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9379-6332","authenticated-orcid":false,"given":"Jeannina A","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Medicine Division of Infectious Diseases University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,12,7]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2006.00639.x"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002191"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13512"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15183"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.3947\/ic.2017.49.3.161"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1879"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1086\/319225"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix696"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706640"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.05265-11"},{"key":"e_1_2_7_12_1","doi-asserted-by":"crossref","unstructured":"AbidiM GutmanJ WeinbergA 1102.Reconstitution of CMV\u2010specific cell\u2010mediated immunity during letermovir prophylaxis in hematopoietic stem cell recipients Open Forum Infectious Diseases Volume7 Issue Supplement_1 October 2020 PageS581 https:\/\/doi.org\/10.1093\/ofid\/ofaa439.1288","DOI":"10.1093\/ofid\/ofaa439.1288"},{"key":"e_1_2_7_13_1","unstructured":"https:\/\/www.viracor\u2010eurofins.com\/test\u2010menu\/30360\u2010cmv\u2010t\u2010cell\u2010immunity\u2010panel\/accessed 3\/12\/20"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13693"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028019847231"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13489"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy295"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13080"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00003"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13636"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13272"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra064928"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2006.00618.x"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2010.03074.x"},{"key":"e_1_2_7_25_1","doi-asserted-by":"crossref","first-page":"e14379","DOI":"10.1111\/ctr.14379","article-title":"Valganciclovir prophylaxis extension from 3 to 6 months in high\u2010risk pancreas\u2010transplant recipients does not impact incidence of cytomegalovirus infection at 12 months","author":"Jorgenson MR","year":"2021","journal-title":"Clin Transplant"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13255"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2007.03.009"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.3138"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00015-13"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13189"},{"key":"e_1_2_7_31_1","doi-asserted-by":"crossref","first-page":"e13570","DOI":"10.1111\/tid.13570","article-title":"Letermovir prophylaxis in solid organ transplant\u2010Assessing CMV breakthrough and tacrolimus drug interaction","author":"Winstead RJ","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13166"},{"key":"e_1_2_7_33_1","volume-title":"Letermovir Versus Valganciclovir to Prevent Human Cytomegalovirus Disease in Kidney Transplant Recipients (MK\u20108228\u2010002)"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01596-09"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/tri.12225"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-4787-4"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2020.01.027"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2010.03114.x"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tid.13766","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/tid.13766","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tid.13766","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T22:44:10Z","timestamp":1699829050000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tid.13766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,7]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.1111\/tid.13766"],"URL":"https:\/\/doi.org\/10.1111\/tid.13766","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,7]]},"assertion":[{"value":"2021-08-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e13766"}}